TANAKA Hideo 田中英夫

Researcher Number	50243613
Other IDs
External Links
Affiliation (based on the past Project Information) *help	2006: 広島大学, 原爆放射線医科学研究所, 助教授 2002 – 2003: 広島大学, 原爆放射線医科学研究所, 助教授 2000 – 2001: 広島大学, 原爆放射能医学研究所, 助教授 1999: 広島大学, 原爆放射能医学研究所, 助手 1995 – 1996: 広島大学, 原爆放射能医学研究所, 助手
Review Section/Research Field	Principal Investigator Hematology / Hematology Except Principal Investigator Hematology / 環境影響評価(含放射線生物学)
Keywords	Principal Investigator Bim / Lyn / Pax-5 / CD19 / molecular response / Src-kinase / cell line / drug-resistance / imatinib / CML … More / 分子遺伝学的効果 / Src kinase / 細胞株 / 耐性 / イマチニブ / 慢性骨髄性白血病 / oncogenesis / plasma call / Myeloma / transcriptional regulation / Myeloma cell / 発癌機構 / 形質細胞 / 骨髄腫 / 転写調節 / 骨髄腫細胞 … More Except Principal Investigator Siva / AML 1 / MDS / multiple myeloma / apoptosis / CD27-CD70 interaction / アポトーシス / CD27-CD70結合 / CD70 / CD27 / 多発性骨髄腫 / DNA repair / Radiation / Atomic bomb / 被曝者 / 被曝 / 被爆者 / 被爆 / 放射線 / DNA修復酵素 / 原爆 / 骨髄異形成症候群 Less

Mechanisms of imatinib-resistance in clinical patients and imatinib-resistant cell line showing over-expression of Lyn in chronic myelogenous leukemia (CML)Principal Investigator
- Principal Investigator
  
  SAKAI Akira, 田中英夫
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Hiroshima University
The significant role for the loss of CD27-expression in myelomagenesis
- Principal Investigator
  
  SAKAI Akira
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  HIROSHIMA UNIVERSITY
Epidemiological and molecular biological study of myelodysplastic syndrome (MDS) among atomic bomb survivors
- Principal Investigator
  
  KIMURA Akiro
- Project Period (FY)
  1999 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  環境影響評価(含放射線生物学)
- Research Institution
  HIROSHIMA UNIVERSITY
ALTERED EXPRESSION OF TRANSCRIPTION FACTOR FOR CD19 GENE IN HUMAN MYELOMA CELLSPrincipal Investigator
- Principal Investigator
  
  TANAKA Hideo
- Project Period (FY)
  1995 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  HIROSHIMA UNIVERSITY

All 2008 2007

All Journal Article Presentation

[Journal Article] Basis and clinical aspects of the molecular therapy -Hematology area-2008
- Author(s)
  Tanaka, H
- Journal Title
  
  Hiroshima Medical Journal (in press)
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591065
[Journal Article] 分子標的治療の基礎と臨床 -血液腫瘍領域における分子標的治療-2008
- Author(s)
  田中英夫
- Journal Title
  
  広島医学 (印刷中)
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591065
[Journal Article] Imatitib therapy in chronic myelogenous leukemia (CML)-importance of molecular monitoring-2007
- Author(s)
  Tanaka, H., et. al.
- Journal Title
  
  Hiroshima Medical Journal 59
  
  Pages: 127-132
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591065
[Journal Article] Treatment with IFNa in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients2007
- Author(s)
  Tanaka, H., et. al.
- Journal Title
  
  European Journal of Haematology 78
  
  Pages: 389-398
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591065
[Journal Article] Treatment with IFNα in vivo Up-regulates Serum Soluble TNF-related Apoptosis Inducing Ligand (sTRAIL) Levels and TRAIL mRNA Expressions in Neutrophils in Chronic Myelogenous Leukemia Patients2007
- Author(s)
  Hideo Tanaka
- Journal Title
  
  Eur J Haemotol. (in press)
- Data Source
  KAKENHI-PROJECT-18591065
[Journal Article] 慢性骨髄性白血病(CML)のイマチニブ治療-分子遺伝学的モニタリングの重要性-2007
- Author(s)
  田中英夫
- Journal Title
  
  広島医学 60(2)
  
  Pages: 84-89
- Data Source
  KAKENHI-PROJECT-18591065
[Presentation] Long-term results and dose effects of the imatinib therapy on chronic phase CML patients2008
- Author(s)
  Tanaka, H., et. al.
- Organizer
  47th Chugoku-Shikoku Meeting of the Japan Socieity of Hematology
- Place of Presentation
  Yamaguchi
- Year and Date
  2008-03-08
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591065
[Presentation] CML慢性期患者のイマチニブ治療の長期成績と初期投与量別に見た解析2008
- Author(s)
  田中英夫
- Organizer
  第47回日本血液学会中国地方会
- Place of Presentation
  山口
- Year and Date
  2008-03-08
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591065
[Presentation] 慢性骨髄性白血病(CML)慢性期患者のイマチニブ治療の長期成績:-BCR-ABL変異とBACH2遺伝子発現解析を含む-2007
- Author(s)
  田中英夫
- Organizer
  第69回日本血液学会総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-12
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591065
[Presentation] 慢性骨髄性白血病(CML)慢性期患者のイマチニブ治療の長期成績: -BCR-ABL変異とBACH2遺伝子発現解析を含む-2007
- Author(s)
  田中英夫
- Organizer
  第69回日本血液学会総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-12
- Data Source
  KAKENHI-PROJECT-18591065
[Presentation] 「分子標的治療の基礎と臨床」血液腫瘍領域における分子標的治療2007
- Author(s)
  田中英夫
- Organizer
  第60回広島医学会総会
- Place of Presentation
  広島
- Year and Date
  2007-11-10
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591065
[Presentation] Long-term results of the imatinib therapy on chronic phase CML patients.-BCR-ABL mutation and BACH2 expression-2007
- Author(s)
  Tanaka, H., et. al.
- Organizer
  69th Annual Meeting of Japanese Society of Hematology 49th Annual Meeting of Japanese Society of Clinical Hematology
- Place of Presentation
  Yokohama
- Year and Date
  2007-10-12
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591065
[Presentation] Molecular-target therapy in the field of the hematological malignancy. In the symposium of the basis and clinical approach of molecular target therapy2007
- Author(s)
  Tanaka, H
- Organizer
  60th Annual Meeting of Hiroshima Medical Association
- Place of Presentation
  Hiroshima
- Year and Date
  2007-11-10
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591065

1. SAKAI Akira (70284221)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
2. KAWANO Michio (40161343)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. KIMURA Akiro (70127645)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. HAYAKAWA Norihiko (40022834)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

TANAKA Hideo 田中 英夫

Research Projects

Research Products

Co-Researchers

Mechanisms of imatinib-resistance in clinical patients and imatinib-resistant cell line showing over-expression of Lyn in chronic myelogenous leukemia (CML)Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The significant role for the loss of CD27-expression in myelomagenesis

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Epidemiological and molecular biological study of myelodysplastic syndrome (MDS) among atomic bomb survivors

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

ALTERED EXPRESSION OF TRANSCRIPTION FACTOR FOR CD19 GENE IN HUMAN MYELOMA CELLSPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Basis and clinical aspects of the molecular therapy -Hematology area-2008

Author(s)

Journal Title

Description

Data Source

[Journal Article] 分子標的治療の基礎と臨床 -血液腫瘍領域における分子標的治療-2008

Author(s)

Journal Title

Description

Data Source

[Journal Article] Imatitib therapy in chronic myelogenous leukemia (CML)-importance of molecular monitoring-2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Treatment with IFNa in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Treatment with IFNα in vivo Up-regulates Serum Soluble TNF-related Apoptosis Inducing Ligand (sTRAIL) Levels and TRAIL mRNA Expressions in Neutrophils in Chronic Myelogenous Leukemia Patients2007

Author(s)

Journal Title

Data Source

[Journal Article] 慢性骨髄性白血病(CML)のイマチニブ治療-分子遺伝学的モニタリングの重要性-2007

Author(s)

Journal Title

Data Source

[Presentation] Long-term results and dose effects of the imatinib therapy on chronic phase CML patients2008

Author(s)

Organizer

Place of Presentation

Year and Date

Description

Data Source

[Presentation] CML慢性期患者のイマチニブ治療の長期成績と初期投与量別に見た解析2008

Author(s)

Organizer

Place of Presentation

Year and Date

Description

Data Source

[Presentation] 慢性骨髄性白血病(CML)慢性期患者のイマチニブ治療の長期成績:-BCR-ABL変異とBACH2遺伝子発現解析を含む-2007

Author(s)

Organizer

Place of Presentation

Year and Date

Description

Data Source

[Presentation] 慢性骨髄性白血病(CML)慢性期患者のイマチニブ治療の長期成績: -BCR-ABL変異とBACH2遺伝子発現解析を含む-2007

Author(s)

Organizer

TANAKA Hideo 田中英夫